The best stocks under $100 to buy today depend on today’s chart. The fact is, 99.9% of these cheap stocks will eventually be worth less than they are right now. That’s why I tell my students to build a watchlist every day.
The best traders watch more stocks than they trade. That’s essential for getting to know the charts of these stocks — these charts will give you valuable info about their future moves. If you study the patterns these stocks follow, you can find opportunities for the kind of small gains that can grow a small account fast.
Today I’ll show you how to build a watchlist for stocks under $100. Read on for the results!
Table of Contents
- 1 What Are the Best Stocks to Buy Under $100 in December 2023?
- 2 Best Stocks Under $100 to Buy in December 2023
- 3 Which Is the Cheapest High-Potential Stock to Buy Right Now?
- 4 What Are the Stocks Under $100 with the Highest Potential?
- 5 Stocks Under $100 FAQs
What Are the Best Stocks to Buy Under $100 in December 2023?
To find the best stocks to buy under $100 in December 2023 requires a top-level stock screener. I use the one in StocksToTrade — I helped design it, so it has all the tools and customizations I look for to create my stock watchlists.
To find watch-worthy stocks under $100, I input the following criteria:
- Last Price ≤ $100
- Last Price ≥ $40
- Volume ≥ 50,000
When I run this screen in December 2023 and sort by percent change, it gives me the following top results:
Best Stocks Under $100 to Buy in December 2023
The best stocks under $100 in December 2023 are:
- CRISPR Therapeutics AG [NASDAQ: CRSP]
- BellRing Brands Inc. [NYSE: BRBR]
- Halozyme Therapeutics Inc. [NASDAQ: HALO]
- Celsius Holdings Inc. [NASDAQ: CELH]
- MoonLake Immunotherapeutics [NASDAQ: MLTX]
This is a watchlist — not a “buy list.”
I’m sharing this so you can see my process. If you want to see more NO-COST watchlists, you can sign up for my weekly watchlist here.
Read on for the best stocks that I’m watching today!
CRISPR Therapeutics AG [NASDAQ: CRSP]
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR’s most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
BellRing Brands Inc. [NYSE: BRBR]
BellRing Brands Inc is a United States-based company engaged in providing nutrition-related products. Its brands, Premier Protein, Dymatize, and PowerBar provides various products including ready-to-drink protein shakes, powders, and nutrition bars. The company’s products are distributed through a diverse network of channels including club, food, drug and mass, eCommerce, convenience and specialty.
Halozyme Therapeutics Inc. [NASDAQ: HALO]
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company’s operations are based in the United States, with minimal long-lived assets located internationally.
Celsius Holdings Inc. [NASDAQ: CELH]
Celsius Holdings Inc engages in the development, marketing, sale, and distribution of functional calorie-burning beverages. It offers flavors including cola, orange, wild berry and lemon iced tea and non-carbonated flavors such as Raspberry Acai Green Tea and Peach Mango Green Tea under the Celsius brand name. The company distributes its products through direct-store-delivery distributors, as well as directly to retailers across various retail segments, including supermarkets, convenience stores, drug stores, nutritional stores, mass merchants, health clubs, spas, gyms, military, and e-commerce websites.
MoonLake Immunotherapeutics [NASDAQ: MLTX]
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.
Which Is the Cheapest High-Potential Stock to Buy Right Now?
To find the cheapest high-potential stocks, you have to study their charts.
Take a look at the 1-year chart for Clean Vision Corp. [OTCPK: CLNV]:
See how many 100% spikes this stock had in the past year? Each one of these spikes was a trading opportunity — that’s the way I’ve made over $8,000 in total earnings trading this stock (click the link to see my individual trades).
However, that’s not a recommendation to “buy” this stock. See how it drops after every spike?
CLNV follows my 7-step pennystocking framework perfectly. This framework isn’t just for penny stocks though… You can also see its patterns play out in higher priced stocks like Tesla Inc. (NASDAQ: TSLA).
This is the chart you have to commit to memory:
Remember this chart well, its the basis for my 7-step framework, @30DayBoot & @completepenny & you must study not to fall prey to greed/ignorance or you'll get wrecked like 90% of traders. It's VITAL to sell into excessive strength/hype, do not just hold & hope like most newbies pic.twitter.com/QsAGHsI6lp
— Timothy Sykes (@timothysykes) February 28, 2021
What Are the Stocks Under $100 with the Highest Potential?
Look up at the charts of the stocks above. Do you see any spikes in their long-term chart? That’s a good sign.